Specific chemotaxis of magnetically labeled mesenchymal stem cells: Implications for MRI of glioma

Molecular Imaging and Biology

Volumn 14, Issue 6, 2012, Pages 676-687

  Bennewitz, Margaret F ^a   Tang, Kevin S ^a   Markakis, Eleni A ^b   Shapiro, Erik M ^a,b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotaxis; Glioma; Iron oxide particles; Mesenchymal stem cell; MRI

Indexed keywords

AGAROSE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ARTICLE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL LABELING; CELL LINEAGE; CELL MIGRATION; CELL TRACKING; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FLUORESCENCE MICROSCOPY; GLIOMA; IN VITRO STUDY; INTERNALIZATION; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TROPISM;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL MIGRATION ASSAYS; CHEMOTAXIS; DEXTRANS; FEMALE; GLIOMA; MAGNETIC PHENOMENA; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; RATS; RATS, INBRED F344; STAINING AND LABELING;

ANIMALIA;

EID: 84870453660     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-012-0553-3     Document Type: Article

References (61)

1. Stupp R, Mason W, van der Bent M, Weller M, Fisher B, Taphoorn M (2005) Radiotherapy plus concomitant and adjuvant temozolamide for glioblastoma. N Engl J Med 352:987-996
2. Jansen E, Dewit L, van Herk M, Bartelink H (2000) Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 56:151-156
3. SageM(1982) Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. AJF AM J Roentgenol 138:887-898
4. Pierallini A, Bonamini M, Pantano P (1998) Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology 40:150-153
5. Carter R, Pretorius P (2007) The use of CT and MRI in the characterization of intracranial mass lesions. Imaging 19:173-184
6. Mechtler L (2008) Neuroimaging in neuro-oncology. Neurol Clin 27:171-201
7. Strupp R, Hegi M, Glibert M, Chakravarti A (2007) Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 16:1405-1409
8. Liang B, Thornton A, Sandler H, Greenberg H (1991) Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75:559-563
9. Allard E, Passirani C, Benoit J (2009) Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 30:2303-2318
10. Clarke J, Chang S (2009) Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci 9:241-246
11. Jacobs A, Kracht L, Gossmann A et al (2005) Imaging in neurooncology. NeuroRx 2:333-347
12. Yang I, Aghi M (2009) New advances that enable identification of glioblastoma recurrence. Nat Rev Clin Oncol 6:648-657
13. Nakamura K, Ito Y, Kawano Y et al (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155-1164
14. Zhang Z, Jiang Z, Jiang F et al (2004) In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. NeuroImage 23:281-287
15. Aboody K (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97:12846-12851
16. Tabatabai G, Bahr O, Mohle R, Eyupoglu I, Boehmler A, Wischhusen J (2005) Lessons from the bone marrow: how malignant gliomas attract adult haematopoietic progenitor cells. Brain 128:2200-2211
17. Badie B, Schartner J (2000) Flow cytometric characterization of tumorassociated macrophages in experimental gliomas. Neurosurgery 46:957-961
18. Strik H, Stoll M, Meyermann R (2004) Immune cell infiltration of intrinsic and metastatic intracranial tumors. Anticancer Res 24:37-42
19. Watanabe T, Tanaka R, Taniguchi Y, Yamamoto K, Ono K, Yoshida S (1998) The role of microglia and tumor-primed lymphocytes in the interaction between T lymphocytes and brain endothelial cells. J Neuroimmunol 81:90-97
20. Badie B, Schartner J (2001) Role of microglia in glioma biology. Microsc Res Tech 54:106-113
21. Birnbaum T, Roider J, Schankin C et al (2007) Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83:241-247
22. Corsten M, Shah K (2008) Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol 9:376-384
23. Hinds K, Hill J, Shapiro E et al (2003) Highly efficient endosomal labeling of progenitor and stemcells with largemagnetic particles allows magnetic resonance imaging of single cells. Blood 102:867-872
24. Nkansah M, Thakral D, Shapiro E (2011) Magnetic poly(lactide-coglycolide) and cellulose particles for MRI-based cell tracking. Magn Reson Med 65:1776-1785
25. Shapiro E, Skrtic S, Sharer K, Hill J, Dunbar C, Koretsky A (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101:10901-10906
26. Shapiro E, Skrtic S, Koretsky A (2005) Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 53:329-338
27. Kalish H, Arbab A, Miller B et al (2003) Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 50:275-282
28. Xin-Qin Kang W-JZ, Song Tu-Sheng, Xiao-Li Xu, Xiao-Jiang Yu, Li D-L, Meng Ke-Wei, Sheng-Li Wu, Zhao Z-Y (2005) Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. World J Gastroenterol 11:3479-3484
29. Naresh Polisetti CVG, Babu PP, Vemuganti GK (2010) Isolation, characterization and differentiation potential of rat bone marrow stromal cells. Neurology India 58:201-208
30. Chen A, Siow B, Blamire A, Lako M, Clowry G (2010) Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res 5:255-266
31. Ma G, QI C, Liu N et al (2011) Efficiently tracking of stem cells in vivo using different kinds of superparamagnetic iron oxide in swine with myocardial infarction. Chin Med J 124:1199-1204
32. Saldanha K, Doan R, Ainslie K, Desai T, Majumdar S (2011) Micrometer-sized iron oxide particle labeling of mesenchymal stem cells for magnetic resonance imaging-based monitoring of cartilage tissue engineering. Magn Reson Imaging 29:40-49
33. Gonzalez-Lara L, Xu X, Hofstetrova K et al (2011) The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Mol Imaging Biol 13:702-711
34. Nakamizo A, Marini F, Amano T et al (2005) Human bone marrowderived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318
35. Xu F, Shi J, Yu B, Ni W, Wu X, Gu Z (2010) Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep 23:1561-1567
36. Ozaki Y, Nishimura M, Sekiya K et al (2007) Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16:119-129
37. Ponte A,Marais E, Gallay N et al (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745
38. Kollar K, Cook M, Atkinson K, Brooke G (2009) Molecular mechanisms involved in mesenchymal stem cell migration to the site of myocardial infarction. Int J Cell Biol 2009:904682
39. Shi M, Li J, Liao L et al (2007) Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 92:897-904
40. Cheng Z, Ou L, Zhou X et al (2008) Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571-579
41. Chien L, Hsiao J, Hsu S et al (2011) In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model. Biomaterials 32:3275-3284
42. Kim D, Kim J, Lee J et al (2009) Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 18:511-519
43. Wu X, Hu J, Zhou L et al (2008) In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. J Neurosurg 108:320-329
44. Park S, Ryu C, Kim S et al (2011) CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 38:97-103
45. Bexell D, Gunnarsson S, Tormin A et al (2008) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Cell Therapy 17:183-190
46. Shapiro E, Sharer K, Skrtic S, Koretsky A (2006) In vivo detection of single cells by MRI. Magn Reson Med 55:242-249
47. Studeny M, Marini F, Champlin R, Zompetta C, Fidler I, Andreeff M (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res 62:3603-3608
48. Gunnarsson S, Bexel D, Svensson A, Siesjo P, Darabi A, Bengzon J (2010) Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNγ-transduced tumor cell immunotherapy of experimental glioma. J Neuroimmunol 218:140-144
49. Xu G, Jiang X, Xu Y et al (2009) Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of gliomas in rats. Cell Biol Int 33:466-474
50. Yong R, Shinojima N, Fueyo J et al (2009) Human bone marrowderived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Δ24-RGD to human gliomas. Cancer Res 69:8932-8940
51. Menon L, Kelly K, Yang H, Kim S, Black P, Carroll R (2009) Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 27:2320-2330
52. Sasportas L, Kasmieh R, Wakimoto H et al (2009) Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. PNAS 106:4822-4827
53. Walczak P, Zhang J, Gilad A et al (2008) Dual-modality monitoring of targeted intraarterial dlivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569-1574
54. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H (2008) Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581-2587
55. Klopp A, Spaeth E, Dembinski J et al (2007) Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67:11687-11695
56. Francois S, Bensidhoum M, Mouiseddine M et al (2006) Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24:1020-1029
57. Henschler R, Deak E, Seifried E (2008) Homing of mesenchymal stem cells. Transfus Med Hemother 35:306-312
58. Kraitchman D, Tatsumi M, Glison W et al (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451-1461
59. Hauger O, Frost E, van Heeswijk R et al (2006) MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 238:200-210
60. Gao J, Dennis J, Muzic R, Lundberg M, Caplan A (2001) The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20
61. Bexell D, Scheding S, Bengzon J (2010) Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther 18:1067-1075